EP
SANA icon

Essential Partners’s Sana Biotechnology SANA Stock Holding History

Essential Partners’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.82K Sell
2,241
-1,059
-32% -$3.41K ﹤0.01% 1327
2026
Q1 		$9.5K Sell
3,300
-13
-0.4% -$51 ﹤0.01% 1281
2025
Q4 		$13.5K Buy
3,313
+10
+0.3% +$45 ﹤0.01% 1053
2025
Q3 		$11.7K Buy
3,303
+3
+0.1% +$11 ﹤0.01% 1102
2025
Q2 		$9.01K Buy
+3,300
New +$6.81K ﹤0.01% 876

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Essential Partners's SANA Position: Q2 2026 in Review

Essential Partners reduced its Sana Biotechnology (SANA) stake by 32% in Q2 2026, selling an estimated $3.41K and leaving 2,241 shares worth $7.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1327.

Essential Partners first reported a position in SANA in Q2 2025 and has held it in 5 quarters since. The position peaked at $13.5K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Essential Partners held 2,241 shares of Sana Biotechnology worth $7.82K as of Q2 2026.
  • Essential Partners sold 1,059 Sana Biotechnology shares in Q2 2026, an estimated $3.41K.
  • Sana Biotechnology made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1327 holding.
  • Essential Partners first reported a position in Sana Biotechnology in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Sana Biotechnology position peaked at $13.5K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.